ATE337790T1 - Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen - Google Patents
Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungenInfo
- Publication number
- ATE337790T1 ATE337790T1 AT01992568T AT01992568T ATE337790T1 AT E337790 T1 ATE337790 T1 AT E337790T1 AT 01992568 T AT01992568 T AT 01992568T AT 01992568 T AT01992568 T AT 01992568T AT E337790 T1 ATE337790 T1 AT E337790T1
- Authority
- AT
- Austria
- Prior art keywords
- cortisol
- hypercortisolaemia
- treat
- related diseases
- agents
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 title 2
- 201000010099 disease Diseases 0.000 title 1
- 229960000890 hydrocortisone Drugs 0.000 title 1
- 239000003352 sequestering agent Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00309725 | 2000-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE337790T1 true ATE337790T1 (de) | 2006-09-15 |
Family
ID=8173362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01992568T ATE337790T1 (de) | 2000-11-02 | 2001-10-30 | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040048830A1 (de) |
| EP (2) | EP1629845A3 (de) |
| JP (1) | JP2004512358A (de) |
| AT (1) | ATE337790T1 (de) |
| AU (1) | AU2002220654A1 (de) |
| DE (1) | DE60122764T2 (de) |
| ES (1) | ES2269504T3 (de) |
| WO (1) | WO2002036105A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010012281A1 (de) * | 2010-03-22 | 2011-09-22 | Fresenius Medical Care Deutschland Gmbh | Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin |
| CN102060941B (zh) * | 2010-11-26 | 2012-12-26 | 漆又毛 | 6-脱氧α-氨基酸衍生物环糊精及制备和应用 |
| MX368167B (es) | 2013-11-25 | 2019-09-23 | Corcept Therapeutics Inc | Moduladores de receptores de glucocorticoides de azadecalina octahidro fusionada. |
| US10813944B2 (en) * | 2016-04-29 | 2020-10-27 | Alveron Pharma B.V. | Cyclodextrins as procoagulants |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU190356B (en) * | 1981-10-27 | 1986-08-28 | Richter Gedeon Vegyeszeti Termekek Gyara Rt,Hu | Process for preparing steroid-gamma-cyclodextrin inclusion complexes with high water-solubility |
| US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
| JP2590983B2 (ja) * | 1987-12-11 | 1997-03-19 | 東ソー株式会社 | 難水溶性抗原の免疫測定方法 |
| DK0447171T3 (da) * | 1990-03-15 | 1994-12-12 | Tanabe Seiyaku Co | Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf |
| US6090794A (en) * | 1990-04-19 | 2000-07-18 | The General Hospital Corporation | Inhibition of neurofibrosarcoma growth and angiogenesis |
| WO1996008265A1 (en) * | 1994-09-12 | 1996-03-21 | The Trustees Of The University Of Pennsylvania | Corticotropin release inhibiting factor and methods of using same |
| US5777073A (en) * | 1994-12-12 | 1998-07-07 | The Salk Institute For Biological Studies | Cyclic CRF antagonist peptides |
| TWI242015B (en) * | 1999-11-29 | 2005-10-21 | Akzo Nobel Nv | 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
-
2001
- 2001-10-30 US US10/415,867 patent/US20040048830A1/en not_active Abandoned
- 2001-10-30 WO PCT/EP2001/012267 patent/WO2002036105A2/en not_active Ceased
- 2001-10-30 AU AU2002220654A patent/AU2002220654A1/en not_active Abandoned
- 2001-10-30 DE DE60122764T patent/DE60122764T2/de not_active Expired - Lifetime
- 2001-10-30 ES ES01992568T patent/ES2269504T3/es not_active Expired - Lifetime
- 2001-10-30 EP EP05111297A patent/EP1629845A3/de not_active Withdrawn
- 2001-10-30 JP JP2002538917A patent/JP2004512358A/ja active Pending
- 2001-10-30 AT AT01992568T patent/ATE337790T1/de not_active IP Right Cessation
- 2001-10-30 EP EP01992568A patent/EP1333842B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002036105A3 (en) | 2002-10-31 |
| WO2002036105A2 (en) | 2002-05-10 |
| DE60122764D1 (de) | 2006-10-12 |
| AU2002220654A1 (en) | 2002-05-15 |
| EP1629845A3 (de) | 2006-03-22 |
| JP2004512358A (ja) | 2004-04-22 |
| DE60122764T2 (de) | 2007-10-11 |
| US20040048830A1 (en) | 2004-03-11 |
| ES2269504T3 (es) | 2007-04-01 |
| EP1333842A2 (de) | 2003-08-13 |
| EP1629845A2 (de) | 2006-03-01 |
| EP1333842B1 (de) | 2006-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE417606T1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
| ATE316786T1 (de) | Behandlung von mukositis | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| EE05419B1 (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| DE50109156D1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| ATE338575T1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| ATE337790T1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
| ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| ATE265225T1 (de) | Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |